کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6006385 1579677 2016 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Role of heparin during endovascular therapy for acute ischemic stroke
ترجمه فارسی عنوان
نقش هپارین در درمان آندوسکوپی برای سکته مغزی ایسکمیک حاد
کلمات کلیدی
سکته مغزی ایسکمیک حاد درمان با آندوسکوک، خونریزی هپارین درون تراپی،
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
چکیده انگلیسی


- Patients who received heparin had significantly lower rates of hemorrhage.
- Heparin-treated patients had nonsignificantly higher reperfusion rates.
- Heparin use during endovascular therapy for AIS patients was found to be safe.

ObjectivesSystemic heparinization has become the mainstay anticoagulant in neurointerventional procedures to prevent thromboembolic complications. Its benefit during endovascular therapy for acute stroke however has not been established. The purpose of this study is to retrospectively evaluate the impact of heparin during endovascular therapy for acute ischemic stroke (AIS).Patients and methodsWe performed a retrospective review of our interventional stroke database from February 2009 to September 2012 for patients with anterior circulation AIS with ICA-T or MCA M1 occlusions. 76 patients were categorized into 2 groups: intraprocedural vs. no intraprocedural heparin use. Outcomes measured included reperfusion (modified TICI scale), cerebral hemorrhages (ECASS criteria), and 90-day outcomes (modified Rankin scale).ResultsBaseline characteristics were similar between heparin and non-heparin treated patients, except for presence of CAD (6% vs. 30%, p = 0.01), Coumadin (0% vs. 11%, p = 0.04), and NIHSS (15.6 ± 5.0 vs. 18.1 ± 4.6, p = 0.03). There was a nonsignificantly higher reperfusion rate achieved in heparin-treated patients compared to non heparin-treated patients (63% vs. 50%, p = 0.35). Patients who received heparin had significantly lower rates of hemorrhage (p = 0.02). Multivariate logistic regression for good outcome revealed only age (OR 0.86; 95% CI 0.78-0.95; p < 0.01), ASPECTS (OR 2.14; 95% CI 1.01-4.50; p = 0.04), and successful reperfusion (OR 19.25; 95% CI 2.37-155.95; p < 0.01) independently associated with mRS 0-2 at 90 days.ConclusionThe use of intraprocedural heparin in patients with AIS from MCA M1 or ICA-T occlusion was found safe. The impact of heparinization is unclear and warrants further evaluation.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Neurology and Neurosurgery - Volume 145, June 2016, Pages 64-67
نویسندگان
, , , , , , ,